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Table 1.  Summary of samples used.
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Pneumonic plague, caused by the gram-negative bacteria Yersinia pestis, has led to millions of human casualties during several major pandemics and has the potential to be employed as a deadly biological warfare agent. For this reason, it is vital that an effective vaccine against Y. pestis be 
created. Currently, a subunit vaccine exists which works by stimulating B-cells (humoral immunity), but it has failed to protect primates in aerosolized bacterial challenges. In an effort to complement the existing vaccine, an alternative vaccine strategy can use both B-cell stimulation and the targeting 
of T cells (cell-mediated immunity) with an antigenic peptide isolated from the bacteria. To determine what proteins may stimulate T cells, bacteria from three different strains of Y. pestis, KIM 5, KIM 6, and KIM 8, were cultured on TBA plates for four days and then in BCS liquid medium at either 26 
or 37°C for four hours. Subproteomic fractionation of different regions of Y. pestis cultures were obtained and examined using 2D-DIGE, size-spin filters, and mixed-mode chromatography to isolate protein fractions that may stimulate T cells. Once differential proteins are selected, future work 
includes determining structure by mass spectrometry, and testing for antigenic peptides on T4 and T8 T cell stimulation assays. 
Discussion
Fig.1. Schematic of cell fractions 
of Y. pestis. An ultracentrifuge is 
able to separate these layers for 
protein collection and testing. 
Type III Secretion System (T3SS) is 
an example of a pathogenic 
mechanism by which bacteria 
infect host cells.
Periplasmic fraction has been shown to elicit a response in T-cells
Further proteomic characterization  research will be continued
 Additional samples will be sent to the Trudeau Institute for T cell testing 
Antigenic peptides will be determined to help develop a vaccine
Vaccine including T cell epitopes will be  tested to prevent Y. pestis infections 
Add vaccine to United States arsenal against bioterrorism
Grow Bacteria
• Y. pestis cultured on TBA plate 
for 4 days
• In BCS liquid culture for 4 
hours at 26 or 37°C
5-part Subproteomic 
Fractionation
• Separate cell into 5 
fractions
TCA Prep
• Exchange sample buffer to 
desired buffer 
Protein Assay
• Determine protein 
concentration
2D-DIGE: 
comparison of protein 
expression
• Labeling with dye
• Electrophoresis (charge and 
size separation)
• Image acquisition and analysis
Collect proteins
• Mass Spectrometry to 
determine structure
• T4 & T8 T cells assays for 
vaccine development 
Mixed-Mode 
Chromatography
• Identify, Quantify, and 
Purify proteins
Yersinia pestis
•Gram-negative bacteria (a)
•Lives in the stomach of fleas (b)
•Causative agent of plague.
•Most lethal pathogen in human history
•Three forms of infection:
•Bubonic
•Swelling of the lymph nodes
•Many epidemics throughout history (c)
•Septicemic
•Infection of the blood
•Pneumonic
•Infection of the lungs
•Can be passed person to person through the air
•Potential bioterrorism agent
•Need to develop a safe and effective vaccine
•Ineffective vaccines
•Killed, whole cell do not offer adequate protection
•Live attenuated vaccine not licensed for human use (3).
•Subunit vaccine targeting B-cells, humoral immunity, has 
been ineffective in primate aerosol challenges (1).
•New approach: make a vaccine that targets T-cells, cell-
mediated immunity, in combination with the B-cell vaccine 
(2). (d)
•How? Proteomics- The collection of proteins an organism is 
expressing at any given time.
•Catalog proteins and better understand pathogenicity in this 
organism
•Detect  specific proteins associated with virulence
•Determine proteins that elicit T cell activity using different 
proteomic samples
(a)
(c) 
(b)
(d) Different banding patterns in gels indicate differences in protein expression between 
the subcellular fractions, bacterial strains, or between temperatures. Confirmation of the 
protein differences between the subcellular fractions is shown in Figure 4. Between the 
bands that are circled notice how there are two bands at 37°C and only one band at 26°C in 
the same position. This indicates there is a difference in Y. pestis expression of proteins when 
the bacteria infects a host. 
In Figure 5, the spots circled demonstrate periplasm proteins differentially expressed 
between the strains. Table 2 gives a comparison of increased protein expression  comparing 
the strains. K537 and K626 appeared to be the most similar suggesting differences seen in 
K837 correlate with absence of the pPCP plasmid. Proteins differentially expressed when this 
plasmid is present suggest its crucial for up regulating proteins. These proteins will be 
subject to further study. Figure 6 show the differential expression of  KIM5 periplasm 
proteins at 26 and 37°C. These proteins may be associated with virulence. These proteins 
are promising for additional testing as antigenic peptides for vaccine development.
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Methods Proteomic Results
Fig.4. KIM5 and KIM6 Subproteomic Fractions.
10.KIM5 26°C IM
11. KIM5 37°C IM
12.KIM6 26°C IM
13. KIM6 37°C IM
14.KIM5 26°C OM
15. KIM5 37°C OM
16.KIM6 26°C OM
17. KIM6 37°C OM
1.KIM5 26°C Peri
2. KIM5 37°C Peri
3.KIM6 26°C Peri
4. KIM6 37°C Peri
5.KIM5 26°C Sol Cy
6. KIM5 37°C Sol Cy
7.KIM6 26°C Sol Cy
8. KIM6 37°C Sol Cy
9.Mark 
Fig. 3. Diagram of mixed-mode 
chromatography.
Fig. 2. How 2D-DIGE works. 
Adapted from: http://www.gelifesciences.com
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Fig.5. 
Periplasm 
fractions, 
2D-DIGE, pH 
3-10.
Red spots-
K537.Blue 
spots-
K626.Green 
spots -K837.
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Fig.6. KIM5 at 26 and 37°C 
Periplasm fractions separated by 
size by size-spin filters.  
1.Mark
2.K526 large tube
3.K526 small tube
4.K526  >100K
5.K526 100-20K
6.K526 <20K
7.Mark
8.K537 large tube
9.K537 small tube
10.K537 >100K
11.K537 100-20K
12.K537 <20K
Comparison Sample Number of 
Increased 
Expression Spots
Cy2 to Cy3 KIM537 2
KIM626 15
Cy5 to Cy3 KIM837 42
KIM626 45
Cy2 to Cy5 KIM537 42
KIM837 26
Table 2.  Differential Protein Expression
• KIM 5- no pgm locus 
• KIM 6- no pgm locus, no pCD1 plasmid
• KIM 8- no pgm locus, no pPCP plasmid
Three Strains of Y. pestis
• 26° C - flea body temperature
• 37° C - human body temperature
Two growing temperatures
• Secretome (Sec)
• Outer membrane (OM)
• Periplasm (Peri)
• Inner membrane (IM)
• Soluble cytosolic  (Sol Cy)
Five protein fractions of gram-negative bacteria
